These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25323305)

  • 61. [Biomarkers of renal impairment and their application in renal function monitoring during treatment with nucleos(t)ide analogues].
    Li HS; Ma H
    Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):234-6. PubMed ID: 27095771
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An update on the strategies used for the treatment of chronic hepatitis B in children.
    Clemente MG; Vajro P
    Expert Rev Gastroenterol Hepatol; 2016; 10(5):649-58. PubMed ID: 26752166
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recent progress in potential anti-hepatitis B virus agents: Structural and pharmacological perspectives.
    Sun D; Zhu L; Yao D; Chen L; Fu L; Ouyang L
    Eur J Med Chem; 2018 Mar; 147():205-217. PubMed ID: 29438889
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treating chronic hepatitis B: today and tomorrow.
    Borgia G; Gentile I
    Curr Med Chem; 2006; 13(23):2839-55. PubMed ID: 17073632
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Advances in the treatment of hepatitis B].
    Ferreira MS; Borges AS
    Rev Soc Bras Med Trop; 2007; 40(4):451-62. PubMed ID: 17876470
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Management of antiviral drug resistance in chronic hepatitis B.
    Bang KB; Kim HJ
    World J Gastroenterol; 2014 Sep; 20(33):11641-9. PubMed ID: 25206270
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Optimal management of hepatitis B virus infection - EASL Special Conference.
    Lampertico P; Maini M; Papatheodoridis G
    J Hepatol; 2015 Nov; 63(5):1238-53. PubMed ID: 26150256
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Treatment of viral hepatitis (I). Treatment of chronic hepatitis B].
    Sánchez-Quijano A; Lissen E
    Enferm Infecc Microbiol Clin; 2006; 24(7):453-61; quiz 462. PubMed ID: 16956535
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Current therapeutic approaches for HBV infected patients.
    Gill US; Kennedy PTF
    J Hepatol; 2017 Aug; 67(2):412-414. PubMed ID: 28629790
    [No Abstract]   [Full Text] [Related]  

  • 70. Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
    Ridruejo E; Adrover R; Silva MO
    Hepatology; 2011 Sep; 54(3):1104-5; author reply 1105. PubMed ID: 21721024
    [No Abstract]   [Full Text] [Related]  

  • 71. The impact of currently licensed therapies on viral and immune responses in chronic hepatitis B: Considerations for future novel therapeutics.
    Gill US; Kennedy PTF
    J Viral Hepat; 2019 Jan; 26(1):4-15. PubMed ID: 30415490
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The current status of antiviral therapy of chronic hepatitis B.
    Asselah T; Ripault MP; Castelnau C; Giuily N; Boyer N; Marcellin P
    J Clin Virol; 2005 Dec; 34 Suppl 1():S115-24. PubMed ID: 16461210
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Research progress on novel antiviral therapeutic drugs for chronic hepatitis B].
    Cai N; Hu P
    Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):295-299. PubMed ID: 38733181
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Advances in new antivirals for chronic hepatitis B.
    Tang Y; Liang H; Zeng G; Shen S; Sun J
    Chin Med J (Engl); 2022 Feb; 135(5):571-583. PubMed ID: 35120358
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Recent advances in the management of chronic hepatitis B.
    Kim SR; Yang J; Kudo M; Hino O
    Hepat Mon; 2011 Aug; 11(8):601-11. PubMed ID: 22140383
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recent data on treatment of chronic hepatitis B with nucleos(t)ide analogues.
    Leung N
    Hepatol Int; 2008 Jun; 2(2):163-78. PubMed ID: 19669301
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunopathogenesis of hepatitis B persistent infection: implications for immunotherapeutic strategies.
    Kondo Y; Ueno Y; Shimosegawa T
    Clin J Gastroenterol; 2009 Apr; 2(2):71-79. PubMed ID: 26192169
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronic hepatitis B: Advances in treatment.
    Santantonio TA; Fasano M
    World J Hepatol; 2014 May; 6(5):284-92. PubMed ID: 24868322
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Treatment of hepatitis B virus infection: present and future].
    Planas R; Morillas RM
    Gastroenterol Hepatol; 2008; 31(6):349-55. PubMed ID: 18570812
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide Analogs.
    Gupta N; Goyal M; Wu CH; Wu GY
    J Clin Transl Hepatol; 2014 Sep; 2(3):202-11. PubMed ID: 26357626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.